The groundbreaking rise of Viagra has consistently remained a benchmark of pharmaceutical success, but its position within the broader industry now triggers questions about potential gains. Copycat versions are eroding patent protection , causing worries that supporting companies significantly dependent to Viagra's once-dominant position could b… Read More